LUCID DIAGNOSTICS INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementCef Purchase Agreement • November 25th, 2022 • Lucid Diagnostics Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledNovember 25th, 2022 Company Industry JurisdictionLucid Diagnostics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: